ClinicalTrials.gg
CompletedNCT05435950SONO-01Updated May 18, 2023

Clinical Investigation on Safety, Performance and Effectiveness of Sono-instruments

An interventional study of Sono-Intruments in Trigger Finger, Trigger Thumb and Carpal Tunnel Syndrome, sponsored by Spirecut. Completed at 1 site in Belgium. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-05-18.

Sponsored by Spirecut · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

Carpal Tunnel (CT) syndrome is a collection of characteristic symptoms and signs that occurs following compression of the median nerve within the CT. In Trigger Finger / trigger thumb (TF), one of the most common causes of hand pain and disability, the flexor tendon causes painful popping or snapping as the patient flexes and extends the digit. In case of failure of non-operative treatments, patients with CT syndrome or TF are operated. Clearly any improvement in surgical device design would be of great advantage to the patient and the surgeon. Spirecut's single use, pre-CE Sono-Instruments (SI) allow the percutaneous treatment of Carpal Tunnel (CT)syndrome and Trigger Finger/thumb (TF) under sonography (instead of open or endoscopic approach). Two models will be assessed in this clinical investigation:

  1. The Carpal Tunnel Sono-Instrument® (CT-SI), for CT syndrome release, by progressively cutting the transverse carpal ligament.
  2. The Trigger Finger Sono-Instrument® (TF-SI), for TF release by progressively cutting the A1 annual pulley.

Using those SI, surgical procedures can be performed without endangering adjacent structures (e.g. median nerve and branches, ulnar pedicle, superficial carpal arch, digital pedicles, flexor tendons).

02

Conditions studied

  • Trigger Finger
  • Trigger Thumb
  • Carpal Tunnel Syndrome
03

In context

Trigger Finger Disorder

93 studies on the registry are indexed under Trigger Finger Disorder; 22 are open to participants now.

This study's enrollment of 30 is below the median of 66 across 75 interventional studies indexed under Trigger Finger Disorder.

Browse Trigger Finger Disorder studies →

Lead sponsor

This is the only study on the registry with Spirecut as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Participants with Carpal tunnel syndrome:

Inclusion Criteria:

  • Adults ≥ 18 years of age;
  • Primary CT confirmed by typical symptoms, signs and altered nerve conduction studies;
  • Pain and/or numbness in the hand which worsen at night (or are present only at night);
  • Participant and investigator signed and dated the Form (ICF) prior to the index-procedure.

Participants with Trigger Finger/thumb:

Inclusion Criteria:

  • Adults ≥ 18 years of age;
  • Typical signs and symptoms of TF/thumb caused by friction or blockade of flexor tendon(s) in digital sheath, without flexion contracture over 30° of the proximal interphalangeal (or interphalangeal for the thumb) joint, confirmed by altered flexor tendon(s) gliding and/or increased thickness of A1 digital pulley under sonography (sonography can be done just before the operation, that is after signature of the ICF);
  • Participant and investigator signed and dated the ICF prior to the index-procedure.

Exclusion criteria:

Participants with one or more of the following conditions are excluded from the study:

  • Dwarfism or participants with small size hand/CT/TF-thumb;
  • Past or active infection;
  • Known allergic reaction to metals;
  • Coagulation problems, with significant risk of per/postoperative bleeding;
  • In case of TF: long evolution, with ankylosis of the proximal interphalangeal joint;
  • In case of CT: severe median nerve dysfunction;
  • Previous facture or dislocation in the operated area or any affection causing malalignment or distortion of the local skeleton due to trauma, arthritis or other causes;
  • Other known clinical risks outweighing the expected clinical benefits or increasing the risk of a postoperative lesion (e.g. tissue adhesions, anatomical abnormalities, neuro-vascular structures in the zone of the intended release, local tumors);
  • Insufficient sonographic identification of the operated tissue;
  • Previous attempt to treat the condition;
  • Currently receiving treatment for CT or TF;
  • to local anesthesia (general, regional or local);
  • Participant unable (vulnerable participant)/unwilling to provide informed consent;
  • Participant is enrolled in another study.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
30 participants (actual)

Study arms

  • Experimental
    Adult participants with Carpal Tunnel syndrome or with Trigger Finger/Thumb

    Device: Sono-Intruments

Interventions

  • DeviceSono-Intruments

    Spirecut's single use, pre-CE Sono-Instruments (SI) allow the percutaneous treatment of Carpal Tunnel (CT) syndrome and Trigger Finger/thumb (TF) under sonography (instead of open or endoscopic approach). Two models will be assessed: * The Carpal Tunnel Sono-Instrument® (CT-SI), for CT syndrome release, by progressively cutting the transverse carpal ligament. * The Trigger Finger Sono-Instrument® (TF-SI), for TF release by progressively cutting the A1 annual pulley.

06

What researchers measure

Primary outcomes

  1. Safety of percutaneous surgery performed with Sono-Instuments

    Number of peri- and post-operative (serious) adverse events, including operative and post-operative complications (e.g. infection), symptomatic recurrences and re-interventions.

    Time frame: During the index procedure

  2. Safety of percutaneous surgery performed with Sono-Instuments

    Number of peri- and post-operative (serious) adverse events, including operative and post-operative complications (e.g. infection), symptomatic recurrences and re-interventions.

    Time frame: Within 1 week after the procedure

  3. Safety of percutaneous surgery performed with Sono-Instuments

    Number of peri- and post-operative (serious) adverse events, including operative and post-operative complications (e.g. infection), symptomatic recurrences and re-interventions.

    Time frame: 6 weeks after the procedure

Secondary outcomes

  1. Performance of Sono-Instruments during percutaneous surgery

    Ease of positioning of Sono-Instruments during percutaneous surgery. A score ranging from 0 (very unsatisfied) to 4 (very satisfied) will be documented by surgeons experienced in performing percutaneous surgery.

    Time frame: During the index procedure

  2. Performance of Sono-Instruments during percutaneous surgery

    Maneuverability of Sono-Instruments during percutaneous surgery. A score ranging from 0 (very unsatisfied) to 4 (very satisfied) will be documented by surgeons experienced in performing percutaneous surgery.

    Time frame: During the index procedure

  3. Performance of Sono-Instruments during percutaneous surgery

    Visibility (location and orientation) of the Sono-Instruments under sonography. A score ranging from 0 (very unsatisfied) to 4 (very satisfied) will be documented by surgeons experienced in performing percutaneous surgery.

    Time frame: During the index procedure

  4. Performance of Sono-Instruments during percutaneous surgery

    Technical success of the surgical procedure, defined as percutaneous surgery as intended without technical difficulties and without conversion to another surgical intervention.

    Time frame: During the index procedure

  5. Pre-operative pain

    Pain is assessed using the Numeric pain Rating Scale (NRS) in rest and activity (e.g. use for light daily activities like eating with the operated hand, putting the clothes on, washing the hands etc.). The 11-point numeric scale ranges from '0' representing one pain extreme (e.g. "no pain") to '10' representing the other pain extreme (e.g. "pain as bad as you can imagine" or "worst pain imaginable").

    Time frame: During screening

  6. Post-operative pain of percutaneous surgery performed with Sono-Instruments

    Pain is assessed using the Numeric pain Rating Scale (NRS) in rest and activity (e.g. use for light daily activities like eating with the operated hand, putting the clothes on, washing the hands etc.). The 11-point numeric scale ranges from '0' representing one pain extreme (e.g. "no pain") to '10' representing the other pain extreme (e.g. "pain as bad as you can imagine" or "worst pain imaginable").

    Time frame: Within 1 week after the procedure

  7. Post-operative pain of percutaneous surgery performed with Sono-Instruments

    Pain is assessed using the Numeric pain Rating Scale (NRS) in rest and activity (e.g. use for light daily activities like eating with the operated hand, putting the clothes on, washing the hands etc.). The 11-point numeric scale ranges from '0' representing one pain extreme (e.g. "no pain") to '10' representing the other pain extreme (e.g. "pain as bad as you can imagine" or "worst pain imaginable").

    Time frame: 6 weeks after the procedure

  8. Clinical effectiveness of percutaneous surgery performed with Sono-Instruments

    Document use of anti-inflammatory/pain medications.

    Time frame: During screening

  9. Clinical effectiveness of percutaneous surgery performed with Sono-Instruments

    Document what the participant cannot do with his/her affected hand.

    Time frame: During screening

  10. Clinical effectiveness of percutaneous surgery performed with Sono-Instruments

    Quick Disabilities of the Arm, Shoulder and Hand (DASH) questionnaire, including 11 items with 5 response options each (1 = no problem with activity, 5 = activity is not possible).

    Time frame: During screening

  11. Clinical effectiveness of percutaneous surgery performed with Sono-Instruments

    Boston Carpal Tunnel Questionnaire Symptom Severity (BCTQ-SS) in patients with carpal tunnel syndrome, including 11 items with 5 response options each (1 = low level of symptoms/difficulty, 5 = highly symptomatic/unable to complete functional tasks).

    Time frame: During screening

  12. Clinical effectiveness of percutaneous surgery performed with Sono-Instruments

    Boston Carpal Tunnel Questionnaire Functional Scale (BCTQ-FS) in patients with carpal tunnel syndrome, including 8 items with 5 response options each (1 = low level of symptoms/difficulty, 5 = highly symptomatic/unable to complete functional tasks).

    Time frame: During screening

  13. Clinical effectiveness of percutaneous surgery performed with Sono-Instruments

    Noting of numbness/pain at night in patients with carpal tunnel syndrome.

    Time frame: During screening

  14. Clinical effectiveness of percutaneous surgery performed with Sono-Instruments

    Quinnell grading system in patients with trigger finger/thumb, including 2 items with 5 response options each (0 = normal movement of the digit, 4 = fixed deformity).

    Time frame: During screening

  15. Clinical effectiveness of percutaneous surgery performed with Sono-Instruments

    Document use of anti-inflammatory/pain medication.

    Time frame: Within 1 week after the procedure

  16. Clinical effectiveness of percutaneous surgery performed with Sono-Instruments

    Document use of anti-inflammatory/pain medication.

    Time frame: 6 weeks after the procedure

  17. Clinical effectiveness of percutaneous surgery performed with Sono-Instruments

    Document what the participant cannot do with his/her affected hand.

    Time frame: Within 1 week after the procedure

  18. Clinical effectiveness of percutaneous surgery performed with Sono-Instruments

    Document what the participant cannot do with his/her affected hand.

    Time frame: 6 weeks after the procedure

  19. Clinical effectiveness of percutaneous surgery performed with Sono-Instruments

    Quick Disabilities of the Arm, Shoulder and Hand (DASH) questionnaire, including 11 items with 5 response options each (1 = no problem with activity, 5 = activity is not possible).

    Time frame: Within 1 week after the procedure

  20. Clinical effectiveness of percutaneous surgery performed with Sono-Instruments

    Quick Disabilities of the Arm, Shoulder and Hand (DASH) questionnaire, including 11 items with 5 response options each (1 = no problem with activity, 5 = activity is not possible).

    Time frame: 6 weeks after the procedure

  21. Clinical effectiveness of percutaneous surgery performed with Sono-Instruments

    Post-operative time to return to activities of daily living as prescribed by the doctor and effectively done by participant.

    Time frame: Within 1 week after the procedure

  22. Clinical effectiveness of percutaneous surgery performed with Sono-Instruments

    Post-operative time to return to work as prescribed by the doctor and effective return to work for participants that are employed.

    Time frame: Within 1 week after the procedure

  23. Clinical effectiveness of percutaneous surgery performed with Sono-Instruments

    Number of days between surgery and washing of the operated hand for the first time.

    Time frame: Within 1 week after the procedure

  24. Clinical effectiveness of percutaneous surgery performed with Sono-Instruments

    Boston Carpal Tunnel Questionnaire Symptom Severity (BCTQ-SS) in patients with carpal tunnel syndrome, including 11 items with 5 response options each (1 = low level of symptoms/difficulty, 5 = highly symptomatic/unable to complete functional tasks).

    Time frame: Within 1 week after the procedure

  25. Clinical effectiveness of percutaneous surgery performed with Sono-Instruments

    Boston Carpal Tunnel Questionnaire Symptom Severity (BCTQ-SS) in patients with carpal tunnel syndrome, including 11 items with 5 response options each (1 = low level of symptoms/difficulty, 5 = highly symptomatic/unable to complete functional tasks).

    Time frame: 6 weeks after the procedure

  26. Clinical effectiveness of percutaneous surgery performed with Sono-Instruments

    Boston Carpal Tunnel Questionnaire Functional Scale (BCTQ-FS) in patients with carpal tunnel syndrome, including 8 items with 5 response options each (1 = low level of symptoms/difficulty, 5 = highly symptomatic/unable to complete functional tasks).

    Time frame: Within 1 week after the procedure

  27. Clinical effectiveness of percutaneous surgery performed with Sono-Instruments

    Boston Carpal Tunnel Questionnaire Functional Scale (BCTQ-FS) in patients with carpal tunnel syndrome, including 8 items with 5 response options each (1 = low level of symptoms/difficulty, 5 = highly symptomatic/unable to complete functional tasks).

    Time frame: 6 weeks after the procedure

  28. Clinical effectiveness of percutaneous surgery performed with Sono-Instruments

    Noting of numbness/pain at night in patients with Carpal Tunnel Syndrome.

    Time frame: Within 1 week after the procedure

  29. Clinical effectiveness of percutaneous surgery performed with Sono-Instruments

    Noting of numbness/pain at night in patients with Carpal Tunnel Syndrome.

    Time frame: 6 weeks after the procedure

  30. Clinical effectiveness of percutaneous surgery performed with Sono-Instruments

    Noting of pillar pain in patients with Carpal Tunnel Syndrome.

    Time frame: Within 1 week after the procedure

  31. Clinical effectiveness of percutaneous surgery performed with Sono-Instruments

    Noting of pillar pain in patients with Carpal Tunnel Syndrome.

    Time frame: 6 weeks after the procedure

  32. Clinical effectiveness of percutaneous surgery performed with Sono-Instruments

    Quinnell grading system in patients with trigger finger/thumb, including 2 items with 5 response options each (0 = normal movement of the digit, 4 = fixed deformity).

    Time frame: Within 1 week after the procedure

  33. Clinical effectiveness of percutaneous surgery performed with Sono-Instruments

    Quinnell grading system in patients with trigger finger/thumb, including 2 items with 5 response options each (0 = normal movement of the digit, 4 = fixed deformity).

    Time frame: 6 weeks after the procedure

  34. Clinical effectiveness of percutaneous surgery performed with Sono-Instruments

    Modified Patel and Bassini's grading system in patients with trigger finger/thumb, including 2 items with 4 response options each (1 = no improvement, 4 = full improvement).

    Time frame: Within 1 week after the procedure

  35. Clinical effectiveness of percutaneous surgery performed with Sono-Instruments

    Modified Patel and Bassini's grading system in patients with trigger finger/thumb, including 2 items with 4 response options each (1 = no improvement, 4 = full improvement).

    Time frame: 6 weeks after the procedure

07

Study locations

1 site
  • Erasme University Hospital
    Brussels, 1070, Belgium
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 18, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05435950
Lead sponsor
Spirecut
Collaborators
Archer Research
Responsible party
Sponsor
First posted
Jun 28, 2022
Start date
Sep 2, 2022
Primary completion
Jan 27, 2023
Completion
Mar 10, 2023
Last update
May 18, 2023

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion